Publication | Closed Access

An open-label pilot study of the efficacy and safety of anakinra in patients with psoriatic arthritis refractory to or intolerant of methotrexate (MTX)

Rheumatoid DisorderRheumatologyOpen-label Pilot StudyMedicineRheumatic DiseasesOsteoarthritisClinical DermatologyInflammatory Rheumatic DiseasePharmacotherapyPsoriatic Arthritis RefractoryDermatologyPsoriatic ArthritisRheumatoid Arthritis